Fermenta Biotech Limited (BSE: 506414)
Health Care · Pharmaceuticals · IN
Rs551.35
+17.77% today · +68.5% 1Y
Fermenta Biotech Limited (BSE: 506414) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $164.18M.
Over the last twelve months the share price has gained 68.5%, trading between 256.40 and 579.65.
Tweenvest scores Fermenta Biotech Limited across four factors: quality 74/100, value 38/100, growth 51/100, dividend 71/100. Its strongest factor is quality.
506414 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $164.18M
- Revenue (TTM)
- $54.04M
- P/E
- 27.04
- EPS
- 20.39
- Dividend yield
- 0.68%
- Beta (5Y)
- -0.38
- 52-week high
- Rs579.65
- 52-week low
- Rs256.40
- Avg volume (3M)
- —
- Shares outstanding
- 28.67M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Accent Microcell LimitedNSEI: ACCENTMIC | $166.91M | Rs669.90 | -0.73% |
| JBM (Healthcare) LimitedSEHK: 2161 | $166.61M | HK$1.60 | -1.85% |
| Cardiol Therapeutics Inc.TSX: CRDL | $166.36M | CA$1.85 | -8.87% |
| JETEMA, Co., Ltd.KOSDAQ: A216080 | $166.12M | ₩6,000.00 | -16.55% |
| TerrAscend Corp.TSX: TSND | $162.66M | CA$0.69 | -8.00% |
| Mayne Pharma Group LimitedASX: MYX | $162.21M | AU$2.85 | +1.42% |
| DAE HWA Pharmaceutical Co., Ltd.KOSDAQ: A067080 | $158.81M | ₩11,610.00 | +1.40% |
| Jagsonpal Pharmaceuticals LimitedNSEI: JAGSNPHARM | $158.68M | Rs231.73 | -4.36% |
Figures last refreshed Oct 4, 2026.